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To ascertain whether steroid therapy evokes dentin hypersensitivity (DH)-like tooth pain, we performed
a study based on compelling evidence from patients receiving steroid therapy. An exploratory study was
conducted using a questionnaire for 220 patients prescribed steroids who attended the Department of
Hematology and Rheumatology of Tohoku University Hospital. Group comparisons between patients
with and without steroid pulse therapy were analysed by statistical means. In this study, any DH-like
tooth pain that commenced subsequent to steroid treatment was deﬁned as steroid-derived (SD)
tooth pain. The prevalence of SD tooth pain was 17.7% (39/220 patients). SD tooth pain was triggered in
many vital teeth by cold and/or hot water (84.2% and 23.7%, respectively) with the pain characterised as
continuous, in contrast to typical DH tooth pain. SD tooth pain was signiﬁcantly more frequent in pulse
therapy patients than in non-pulse therapy patients (p < 0.05). Logistic regression analysis adjusted for
age and sex showed similar results (odds ratio ¼ 3.74, p ¼ 0.013). Moreover, a positive correlation was
observed between the steroid dose and pain score (r ¼ 0.642). Dose reduction or discontinuation of
steroid therapy relieved SD tooth pain in all cases. Thus, steroid therapy can evoke DH-like tooth pain
during treatment.
© 2016 The Authors. Production and hosting by Elsevier B.V. on behalf of Japanese Pharmacological
Society. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).1. Introduction
Dentin hypersensitivity (DH) is a common oral condition char-
acterised by intense, transient pain induced by stimulation or irri-
tation of exposed dentin, and is generally elicited in response to
chemical, cold, tactile, or osmotic stimuli (1). Numerous informal
reports on social media (e.g., weblogs, Twitter, and Facebook) have
revealed the prevalence of severe DH-like tooth pain in patients
taking steroids. Several of these reports have stated that this pain is
among themost irritating of steroid-derived side effects, alongwith
having a puffy face caused by water retention. However, DH-like
tooth pain is not documented in the academic literature as one of
the side effects of steroid therapy, although steroids have many. Shoji).
rmacological Society.
g by Elsevier B.V. on behalf of Japa
d/4.0/).well-known side effects (e.g., lipodystrophy, neuropsychiatric dis-
orders, skin disorders, muscle cramps, and weakness in proximal
muscles) (2).
Paradoxically, therapies involving corticosteroids are well
known to relieve pain because of their anti-inﬂammatory and/or
anti-oedema effects (3). However, it is unknown whether steroid
administration can inﬂuence the pain threshold. We recently found
that, using a rat model, prednisolone induces microglial activation
speciﬁcally in the subnucleus caudalis, and not in other nuclei of
the trigeminal sensory complex (4), where the primary sensory
nerves innervating the pulp project. This ﬁnding suggests that
steroid therapy may be associated with DH-like tooth pain in
patients.
Here, we surveyed patients undergoing steroid therapy in an
exploratory study. We used a questionnaire that included items
exploring sex, age, primary disease, steroid dose, experience of DH-
like tooth pain, and pain characteristics (e.g., triggers and severity)nese Pharmacological Society. This is an open access article under the CC BY-NC-ND
Table 1
Distribution of patients with steroid treatment (n ¼ 220).
Variables N (%)
Pain () 181 (82.27)
(þ) 39 (17.73)
Pulse () 203 (92.27)
(þ) 17 (7.73)
Age 40> 69 (31.36)
40e59 79 (35.91)
59< 72 (32.73)
Sex Men 40 (18.18)
Women 180 (81.82)
SLE () 127 (57.73)
(þ) 93 (42.27)
RA () 150 (68.18)
(þ) 70 (31.82)
Other diseases () 121 (55.00)
(þ) 99 (45.00)
SLE, systemic lupus erythematosus; RA, rheumatoid arthritis; ‘Other
diseases’ include Sj€ogren's syndrome, Takayasu's arteritis, mixed
connective-tissue disease, and dermatomyositis.
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and DH-like tooth pain.
2. Materials and methods
2.1. Study population
The subjects comprised 220 patients (40males and 180 females)
with a mean age of 49.9 years (range: 17e87 years) who attended
and received steroid therapy at the Department of Hematology and
Rheumatology of Tohoku University Hospital. In this study, a con-
trol group of non-steroid subjects was not included because our
preliminary survey showed all non-steroid subjects who met the
inclusion and exclusion criteria described below did not suffer from
DH-like tooth pain. The most common primary diseases for which
patients were prescribed steroid therapy were systemic lupus er-
ythematosus (SLE; n ¼ 93), rheumatoid arthritis (RA; n ¼ 70),
Sj€ogren's syndrome (n ¼ 17), Takayasu's arteritis (n ¼ 16), mixed
connective tissue disease (n ¼ 9), and dermatomyositis (n ¼ 5).
Patients who experienced tooth pain before steroid therapy, dental
caries (including wedge-shaped defects), and/or had ﬁve or fewer
remaining vital teeth were excluded from the study after clinical
examination (dental checkup) at the Department of Oral Diagnosis
of Tohoku University Hospital. The present study was approved by
the Ethics Committee of Tohoku University Graduate School of
Dentistry (approval no. 2011/22-31). Written informed consent was
obtained from all participants or their guardians (17e19-year-old
participants). This survey was conducted following the ethical
principles of medical investigation involving human subjects under
the Helsinki Declaration of the World Medical Association (http://
www.wma.net).
2.2. Study design
An exploratory study using a questionnaire was carried out at
Tohoku University Hospital between June 2011 and July 2015. The
questionnaire was administered once and patients were asked
questions on items such as sex, age, primary disease, treatment
received (e.g., steroid therapy and/or steroid pulse therapy), expe-
rience of DH-like tooth pain, and pain characteristics (e.g., site,
onset, triggers, and the pain severity score expressed on a visual
analogue scale [VAS]). Steroid pulse therapy comprised methyl-
prednisolone administration (500e1000 mg/day, i.v.) for 3 days.
Non-pulse therapy consisted of prednisolone administration
(1e200 mg/day, p.o.). We compared the maximum pain sensation
(VAS based on patient recall) with the present maximum pain
sensation (VAS described at that time). Steroid doses at these time
points were determined using the patients' medical charts.
Changes in the pain score were compared before and after reduc-
tion or discontinuation of the steroid. For the purposes of this study,
any DH-like tooth pain that commenced subsequent to taking
steroids was deﬁned as ‘steroid-derived (SD) tooth pain’ after a
dental checkup according to the inclusion and exclusion criteria
described above. We also examined the effects of dental treatments
generally provided for DH, which were delivered upon patient
request for alleviation of SD tooth pain. These DH treatments
included application of MS Coat ONE (Sun Medical Co., Ltd., Mor-
iyama, Japan), Teethmate Desensitizer (Kuraray Noritake Dental
Inc., Tokyo, Japan), and Saforide (Bee Brand Medico Dental Co., Ltd.,
Osaka, Japan).
2.3. Statistical analysis
The chi-squared test was used for comparison of qualitative
data. Fisher's exact test was used for comparison of steroid pulsetherapy and presence of tooth pain because of the small expected
value. Logistic regression analysis was then applied to estimate the
odds ratio (OR) of steroid pulse therapy for presence of tooth pain
adjusting for age and sex. To consider the effect of diseases on tooth
pain, the presence of SLE, RA, and other diseases was added to the
model.
The relationship between steroid dose and pain sensation
evaluated by the VAS was analysed by calculating the correlation
coefﬁcient (r). Signiﬁcant differences in tooth pain as quantiﬁed by
the VAS at the maximum steroid dose and after discontinuation or
dose reduction were determined using the paired t-test. Statistical
analyses were performed using PASW statistics, v18.0 (SPSS Inc.,
Chicago, IL, USA). Logistic regression analyses were conducted us-
ing STATA SE version 14.1 (Stata Corp, College Station, TX, USA).
Differences were considered signiﬁcant at p < 0.05.
3. Results
3.1. Prevalence of SD tooth pain in patients receiving pulsed and
non-pulsed steroid therapy
As shown in Table 1, the prevalence of SD tooth pain in patients
taking steroids was 17.7% (39/220 patients). There were no signif-
icant differences in the prevalence between sex (p ¼ 0.7135) or
amongst patients with SLE (n ¼ 93), RA (n ¼ 70), or other diseases
(n¼ 97) as the primary disease (p¼ 0.4374). Thirty-six patients had
more than one primary disease. The prevalence of SD tooth pain
was signiﬁcantly more frequent in patients treated with steroid
pulse therapy (41.2%; 7/17 patients) than in those receiving non-
pulse therapy (15.8%; 32/203 patients; p < 0.05) (Fig. 1).
Table 2 shows the results of logistic regression analysis. After
adjusting for age and sex, logistic regression analysis showed that
steroid pulse therapy was signiﬁcantly associated with SD tooth
pain (OR ¼ 3.74, p ¼ 0.013). Steroid pulse therapy remained
signiﬁcantly associated with SD tooth pain after considering the
effects of diseases (OR ¼ 3.34, p ¼ 0.029), indicating that the effect
of diseases on SD tooth pain was small.
3.2. Relationship between prednisolone dose and pain severity and
the effect of steroid discontinuation or dose reduction on SD tooth
pain
A positive correlation between steroid dose (prednisolone) and
pain score was observed (r ¼ 0.642) (Fig. 2). The highest pain score
Fig. 1. Prevalence of steroid-induced tooth pain in patients receiving pulsed and
non-pulsed steroid therapy. Responses to a questionnaire exploring the development
of tooth pain following steroid administration. Patients were subdivided by the type of
therapy received and asked whether they experienced tooth pain subsequent to
starting therapy. Differences between the groups were statistically analysed using the
chi-squared test, with p < 0.05 (*) considered to be signiﬁcant.
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steroid was administered and then decreased concomitant with
dose reduction or discontinuation of the steroid in all cases (Fig. 3).
Mean differences in pain scores before and after reduction or
discontinuation of the steroid were 41.36 (p < 0.001) for all
cases,43.20 (p < 0.001) for reduction, and35.76 (p¼ 0.0057) for
discontinuation. After reduction or discontinuation of the steroid,
66.7% of patients with pain (26/39) sufﬁciently recovered to record
a zero pain score, with the remainder reporting decreased (but
continuous) pain. Speciﬁcally, all patients who discontinued steroid
therapy achieved zero pain (7/7; 100%). Of the remaining 32 pa-
tients who only received dose reduction, a zero pain score was
achieved in 19 patients, with pain remaining in 40.6% (13/32) of
patients.3.3. Features of SD tooth pain
Fig. 4A shows the frequency of different triggers of SD tooth
pain. Approximately 84% of patients felt pain when drinking cold
water and approximately 24% felt pain even when drinking hot
water. The pain simultaneously occurred in several vital teeth in all
cases (data not shown). In particular, SD tooth pain was evoked
even in teeth without obvious root exposure. It was characterisedTable 2
Results of logistic regression analysis for tooth pain (n ¼ 220).
Age and sex adjusted
Odds ratio (95% conﬁdence interval)
Pulse () 1.00
(þ) 3.74 (1.33e10.55)
Age 40< 1.00
40e59 0.91 (0.40e2.07)
59< 0.47 (0.18e1.20)
Sex Men 1.00
Women 1.19 (0.45e3.13)
SLE () e
(þ) e
RA () e
(þ) e
Other diseases () e
(þ) e
SLE, systemic lupus erythematosus; RA, rheumatoid arthritis; ‘Others’ includes S
dermatomyositis.as continuous pain (97.4%; 38/39 patients), in contrast to the
transient pain generally associatedwith ‘true’ DH tooth pain. Fig. 4B
shows the degree of SD tooth pain, with approximately 64% of
patients ﬁnding it ‘tolerable’, although 31% found the symptoms to
be ‘intolerable’. Almost all patients expressed that the pain made
them feel ‘anxious (intolerable and tolerable)’ (Fig. 4B).3.4. Effects of dental treatments generally provided for DH
Dental treatment to address SD tooth painwas provided to 15 of
the 39 patients with pain, at their request. This treatment
decreased tooth pain but was only temporarily effective, lasting
1e7 days before the pain returned to pre-treatment levels.4. Discussion
Adrenocorticosteroid, a glucocorticoid hormone produced by
the adrenal cortex, is widely applied for the treatment of various
diseases because of its strong anti-inﬂammatory and immunoreg-
ulatory effects (5e7). However, it has not been shown to induce
pain or increase pain sensations in any organ. In the present study,
we demonstrated that patients receiving steroid therapy frequently
experienced severe tooth pain during medication, which we
deﬁned as ‘steroid-derived (SD) tooth pain’. This pain was more
frequently observed in patients receiving steroid pulse therapy
than patients receiving non-pulse therapy (p < 0.05; Fig. 1). Logistic
regression analysis also showed that steroid pulse therapy was
signiﬁcantly associated with SD tooth pain after adjusting for age
and sex (OR ¼ 3.74, p ¼ 0.013; Table 2) and the effects of diseases
(OR ¼ 3.34, p ¼ 0.029; Table 2). Additionally, there was a positive
correlation between the dose of prednisolone and pain sensation
(Fig. 2), and pain was reduced upon reduction of steroid dose and
completely disappeared after discontinuation of steroid therapy
(Fig. 3). These ﬁndings suggest a potential relationship between
steroid therapy and induced tooth pain (SD tooth pain). Symptoms
of SD tooth pain imitate DH, which is a common global oral
symptom associated with exposed dentinal surfaces. This symptom
may lead dentists to misdiagnosis patients for pain control. Here,
we characterised the differences between SD tooth pain and true
DH pain as follows: (i) the pain was not transient, but continuous
and severe; (ii) the pain was triggered by both cold and hot water
(Fig. 4A); (iii) the pain occurred not only in one tooth, but in mul-
tiple vital teeth simultaneously; (iv) the pain was evoked even in
teeth without obvious root exposure; (v) standard DH treatment
was effective at only temporarily reducing pain; and (vi) the painMultivariate adjusted
p-Value Odds ratio (95% conﬁdence interval) p-Value
1.00
0.013 3.34 (1.13e9.87) 0.029
1.00
0.816 0.93 (0.41e2.15) 0.871
0.114 0.48 (0.18e1.27) 0.138
1.00
0.73 1.22 (0.45e3.28) 0.696
1.00
0.85 (0.26e2.71) 0.778
1.00
0.68 (0.25e1.86) 0.453
1.00
0.96 (0.31e2.99) 0.944
j€ogren's syndrome, Takayasu's arteritis, mixed connective-tissue disease, and
Fig. 2. Relationship between prednisolone dose and pain severity. The magnitude of
tooth pain was quantiﬁed using a visual analogue scale (VAS) and plotted against the
prednisolone dose. A correlation analysis was performed to determine the relationship
between these parameters.
Fig. 3. Effect of steroid discontinuation or dose reduction on steroid-derived tooth
pain. Magnitude of steroid-induced tooth pain at the maximum steroid dose and after
discontinuation or dose reduction of the steroid was quantiﬁed on the same VAS used
in Fig. 2. Lines indicate the direction of change in pain severity after dose reduction
(solid lines) or complete discontinuation (dotted lines). Mean differences in pain scores
before and after reduction or discontinuation of the steroid were41.36 (p < 0.001) for
all cases, 43.20 (p < 0.001) for reduction, and 35.76 (p ¼ 0.0057) for discontinuation
(paired t-test).
Fig. 4. Features of steroid-derived tooth pain. (A) Triggers of steroid-derived tooth
pain. Numbers of patients experiencing pain in response to each trigger are shown. (B)
General pain severity. The pain was tolerable in most cases.
Table 3
Summary of differences in the manifestations of SD tooth pain and true DH pain.
SD tooth pain DH pain
Duration Continuous Transient
Intensity Severe Not severe
Thermal trigger Both cold and
hot stimulation
Usually cold
stimulation
Causal teeth number Multiple One or a few
Root exposure Not related Causally related
Standard DH treatment Temporarily effective Effective
Reduction/discontinuation
of the steroid
Effective to
diminish/resolve
Not effective
SD, steroid-derived; DH, dentin hypersensitivity.
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steroid. Table 3 summarises the differences in the manifestations of
SD tooth pain and true DH pain. Interestingly, our preliminary
survey showed all non-steroid subjects who met the study inclu-
sion and exclusion criteria did not suffer from DH-like tooth pain
characterised by the manifestations above (data not shown).
To our knowledge, this is the ﬁrst report to demonstrate a close
causal relationship between steroid therapy and tooth pain that isquite different from DH, although the symptoms are similar. The
mechanisms underlying SD tooth pain remain to be determined,
but may be caused by central (central nervous system neurons)
and/or peripheral (tooth pulp) systems. Some studies have sug-
gested a relationship between steroid use and histological reactions
in the brain, as steroids can cross the bloodebrain barrier (8) and
the brain expresses steroid receptors (9,10). In addition, steroid
administration induces degeneration and cell death in neurons
(11e13). However, these reports showed no evidence to explain the
origin of SD tooth pain. We recently reported that, following steroid
administration, particular glial cells are activated in the subnucleus
caudalis of the trigeminal sensory complex of rats, where trigemi-
nal primary afferent ﬁbres innervating orofacial areas project (4).
Our ﬁndings may indirectly show the possible relationship be-
tween steroid administration and trigeminal nociception. At pre-
sent, we cannot completely explain why external stimuli (cold
water, hot water, and wind) evoke only tooth pain after steroid
N. Shoji et al. / Journal of Pharmacological Sciences 132 (2016) 187e191 191administration without affecting other oral tissues, as the trigem-
inal primary afferent ﬁbres from the subnucleus caudalis innervate
not only the dental pulp but also other oral tissues. Consequently,
we consider that a peripheral (afferent nerve ﬁbre) mechanism,
rather than a central one, likely underlies SD tooth pain.
Regarding the peripheral effect of steroid administration, it has
been reported that steroids inhibit dentin formation in a dose-
dependent manner in prenatal rats (14); however, there is no
published evidence that steroids induce morphological changes in
the tooth pulp. Physiological evidence of the hydrodynamic theory
(15), which is the main proposed mechanism of DH pain, suggests
that pain sensation is induced by ﬂuid movement within the
dentinal tubules in response tomechanical, osmotic, or evaporative
stimuli. This could also be a potent peripheral mechanism under-
lying SD tooth pain. The dental pulp, surrounded by rigid dentin
walls, has much lower interstitial compliance for the pulp tissue to
extend or shrink (16) compared with other tissues such as skin and
muscle, which have relatively high compliance (17,18). Because the
mineralocorticoid activity of prednisolone and/or methylprednis-
olone is reported to induce peripheral oedema in the skin (19), if
this inﬂuences pulp tissue, then induced oedema could facilitate
ﬂuid movement within the dentinal tubules in response to external
stimuli. Indeed, it is suggested that hypersensitivity to thermal
changes in pulp hyperaemia is strongly related to oedema caused
by plasma extravasation (20). Thus, we hypothesise that excessive
tissue pressure exerted by pulpal oedema after steroid adminis-
tration could contribute to the mechanisms underlying SD tooth
pain. Moreover, SD tooth pain was not transient, but continuous
and severe compared with general DH pain. One possibility is that
sensory neuropeptides, such as calcitonin gene-related peptide or
substance P, and/or vasodilatation evoked thereof may relate to the
onset of SD tooth pain. In this respect, we previously demonstrated
that vasodilator responses elicited by noxious stimulation via an-
tidromic activation of nociceptive nerve ﬁbres occurred in the
dental pulp (axon reﬂex vasodilation), suggesting that the spread of
neurogenic inﬂammation was feasible in the dental pulp with rich
nerve ﬁbres (21). Unfortunately, SD tooth pain could not be relieved
by treatment generally performed for DH, presumably because the
excessive oedema-induced tissue pressure in the dental pulp could
not be reduced by such dental treatment.
Thus, we demonstrated the possible relationship between ste-
roid therapy and DH-like tooth pain. However, our data could not
show the results from a long-term follow-up because of the cross-
sectional nature of this study. Therefore, we could not reveal the
detailed transition of pain in each patient. Further study is needed
to clarify this DH-like tooth pain and delineate the mechanisms by
which this pain occurs.
5. Conclusions
We have validated anecdotal information that suggests charac-
teristic tooth pain occurs as a side effect of steroid therapy. Such
pain bears similarity to DH (e.g., reversibility and occurrence in the
absence of inﬂammation), but is distinguished by the continuous
and severe nature of the pain and its induction by hot water
simultaneously in multiple vital teeth without obvious root expo-
sure. In addition, this pain was diminished or resolved with
reduction or discontinuation of steroid therapy. These ﬁndings aresigniﬁcant for clinicians prescribing steroid agents and require
further investigation to clarify the mechanisms by which steroids
induce such pain and the proper treatment strategy without
necessitating discontinuation of steroid treatment.
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